Best Stock to Buy: Eli Lilly Stock vs. Novo Nordisk Stock

By Parkev Tatevosian, CFA – Aug 12, 2025 at 10:40AM

NYSE: LLY

Eli Lilly

Market Cap

$601B

Today's Change

(0.36%) $2.27

Current Price

$637.49

Price as of August 12, 2025, 2:01 p.m. ET

Investors have a tough choice between these two excellent companies.

Eli Lilly (LLY 0.36%) and Novo Nordisk (NVO 0.02%) are competing in the market for weight loss and diabetes treatments.

*Stock prices used were the afternoon prices of Aug. 9, 2025. The video was published on Aug. 11, 2025.

About the Author

A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history. You'll often find him writing about stocks in the consumer goods and technology sectors.

TMFParkev

@TMFParkev

Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services